Abstract
Background
Facial acne scars are a prevalent concern, leading to the development of various treatment modalities.
Objectives
This review aims to explore the latest advancements in the treatment of facial acne scars, focusing on both surgical and non‐surgical methods.
Methods
The non‐surgical treatments reviewed include topical medications (such as retinoids and alpha hydroxy acids) and non‐invasive procedures (like microdermabrasion and chemical peels). Surgical options discussed are punch excision, subcision, and fractional laser treatments.
Results
Combination therapy, integrating both surgical and non‐surgical approaches, is frequently utilized to achieve optimal results in scar improvement.
Conclusion
Recent advancements in the treatment of facial acne scars provide promising options for individuals seeking improvement. However, these treatments have associated risks and potential adverse effects, highlighting the importance of consulting a dermatologist before beginning any treatment regimen.
Keywords: acne scars, combined treatment, medical therapy, surgical therapy, treatment
1. INTRODUCTION
Acne is a common chronic inflammation of hair follicles and sebaceous glands, affecting about 85% of adolescents. 1 and acne inflammation can lead to varying degrees of scar formation. 2 In the context of acne patients, the prevalence and risk factors associated with acne scarring are explored in‐depth in the study conducted by Liu L et al., 3 shedding light on the commonality and contributing elements to acne scars in this population. Acne scars, an important aesthetic issue for patients, can cause various facial disfigurement and psychological disorders 1 , 4 5 and affect their quality of life. 6 , 7 , 8 Acne is a chronic inflammation of the hair follicle sebaceous gland caused by multiple factors (Figure 1), mainly related to androgens, increased sebum secretion, abnormal keratinization of hair follicles and sebaceous glands, proliferation of Propionibacterium acnes, and inflammatory reactions of lymphocytes, macrophages, and neutrophils. 9 Acne lesions are prone to occur on the cheeks and forehead. After healing, acne scars are often left on the face, which may be related to abnormal degradation of facial collagen. Acne scars can be divided into atrophic acne scars, hypertrophic acne scars, and keloids, among which atrophic acne scars are the most common. 10
FIGURE 1.
Etiology of acne.
Innovations in acne grading are addressed in the study by Liu L et al. 11 with the development of “AcneGrader,” an ensemble pruning of deep learning base models, offering a novel approach to effectively grade acne severity. Atrophic acne scars are caused by inflammation that destroys deep dermal structures, followed by abnormal synthesis and degradation of type I and type III collagen, and tissue contraction resulting in skin indentation. Atrophic acne scars can be classified into three types based on their shapes: ice‐pick type, rolling type, and boxcar type (Figure 2). The ice‐pick type scar is narrow and deep, with a “V” shape, and the surface width is usually less than 2 mm, extending to the deep dermis or subcutaneous tissue; the rolling type scar is shallow and wide with a soft edge, with a diameter of more than 4 mm, and the dermis and subcutaneous tissue have a chaotic fibrous structure with a wavy “M” appearance; the boxcar type scar is round to oval, with a clear edge, and the surface opening is wider than that of the ice‐pick type scar, with a wider bottom. The cross‐section is similar to a “U” shape. Hypertrophic acne scars are formed by excessive proliferation of fibroblasts and collagen synthesis greater than degradation, a common acne sequela after healing.
FIGURE 2.
The shape of atrophic acne scars.
At present, there are many methods for treating acne scars. Traditional treatment methods include skin abrasion, chemical peeling, scarring drill excision, tissue filling, micro‐needle therapy, scarring drill elevation, thread lifting, and photodynamic therapy, while emerging therapies such as mesenchymal stem cells (MSCs) and their derivatives are also available (Figure 3). Currently, laser therapy is a first‐line therapy for acne scars, with the advantages of good efficacy and a short recovery period. Still, after treatment, it may cause adverse reactions such as pain, erythema, edema, and inflammatory pigmentation. 12 In recent years, many studies have also used stem cells and their derivatives for treating acne scars, among which MSCs and their derivatives are the most commonly used. In addition, combination therapy with various methods is also possible, and combination therapy often achieves more satisfactory efficacy than a single treatment. This article aims to provide a brief overview of traditional and emerging treatments for acne scars and their advantages and disadvantages.
FIGURE 3.
Treatments of acne scars.
2. NON‐SURGICAL TREATMENT
2.1. Photonic treatment
Photonic treatment mainly refers to laser treatment and radio frequency treatment. According to the different wavelengths of lasers, they are divided into ablative lasers and non‐ablative fractionated lasers. Ablative lasers use high heat to vaporize the skin surface, accelerating the effect of tissue removal and creating scabs after treatment. Non‐ablative fractionated lasers are a kind of laser emission mode which divides a beam of laser into several discontinuous weak light spots acting on the skin, causing the water in the tissue to absorb the laser energy and vaporize, forming multiple small columnar structures of microthermal injury zones called microthermal zones (MTZs), while the tissue between MTZs remains intact. It can quickly produce repair reactions, stimulate collagen regeneration and repair, and significantly improve scar tissue. 13 Radiofrequency treatment involves inserting specific electrodes into unaffected skin and discharging them, producing both ablative and coagulative microthermal injury to the epidermis and dermis, stimulating fibroblasts in the dermis and causing collagen resynthesis, promoting tissue healing and repair, and significantly improving scars.
2.2. Ablative lasers
Ablative lasers have been widely used in the surface repair and treatment of atrophic acne scars. Common ablative lasers for treating acne scars include 10600 nm CO2 and 2940 nm pulsed Er: YAG lasers. 2 10600 nm CO2 lasers belong to the far‐infrared spectrum and produce many microthermal treatment zones, which can activate the formation of new collagen proteins and epithelial regeneration. 14
A retrospective study by Fang et al. showed that the efficacy of 10600 nm CO2 laser treatment for atrophic acne scars in Asians is positively correlated with treatment duration, and the duration of persistent post‐treatment pigmentation is less than 3 months, often resulting in better prognosis. 15 Gala et al. conducted a split‐face study of 30 patients, using 10600 nm CO2 lasers on one side of the face and intradermal injection of platelet‐rich plasma (PRP) on the other. The therapeutic effects of both groups were satisfactory, but combined therapy could improve atrophic scars better. 16 Zhou et al. used a 10600 nm CO2 laser combined with allogeneic stem cells and found that this treatment could improve skin elasticity and hydration. Histological examination showed an increase in the density of dermal collagen and elastic fibers. 17 Alaa et al. conducted a split‐face study of 40 patients with different types of atrophic acne scars. Each group consisted of 20 patients. The first group received a subcutaneous incision and cross‐linked sodium hyaluronate filler injection on one side of the face, the second group received a subcutaneous incision and 10,600 nm CO2 lasers on the other side of the face, and the third group received simple subcutaneous excision. The results showed no statistically significant difference in efficacy between the first and second groups; both were better than the third group. 18 Cheng et al. conducted three treatments of 10600 nm CO2 lasers for 19 patients. They found that the final clinical effective rate was 68.4%, concluding that it could effectively improve mild to moderate acne scars.
10600 nm CO2 laser is currently one of the most effective methods for treating acne scars, using photothermal energy to stimulate the regeneration of dermal collagen. Still, it is often accompanied by adverse reactions such as erythema, edema, and pigmentation within a short period. 19 , 20 , 21
2.3. Non‐ablative lasers
Non‐ablative lasers include pulsed dye lasers (PDL) with wavelengths ranging from 585 to 600 nm, 1320 nm ND: YAG lasers, 1450 nm diode lasers, and 1550 nm erbium glass lasers, which help to reduce boxcar‐type atrophic acne scars. 13 At the histology and cellular tissue level, 675 nm lasers can stimulate collagen resynthesis, especially significantly increasing the number of fine and new collagen fibers. 13 Cannarozzo treated 24 acne scar patients with three treatments of 675 nm lasers, significantly improving all patients' scars with no adverse reactions. 22 , 23
Rogachefsky et al. studied using 1320 nm Nd: YAG lasers to treat atrophic or mixed acne scars 24 and found that the scars improved. Sadick et al. used 1320 nm Nd: YAG lasers to treat acne scars and concluded the same. 25 Soo Ran Lee et al. used 1550 nm erbium glass lasers to treat atrophic acne scars and found that the scars improved significantly, especially in patients aged 25 or younger. In addition, they found that combining 1550 nm fractionated lasers with tretinoin was more effective than laser monotherapy for ice‐pick‐type scars. 26
2.4. Chemical peel therapy
Chemical peeling, chemexfoliation, or chemosurgery is a popular skin beauty treatment for rejuvenation. The most commonly used chemical peeling agents are acid substances, including alpha‐hydroxy acids (AHAs) such as glycolic acid and lactic acid; beta‐hydroxy acids (BHAs) such as salicylic acid; trichloroacetic acid (TCA); Jessner's solution; and full‐trans retinoic acid. Emerging chemical peel agents such as pyruvic acid, esterified beta‐hydroxy acids, salicylic acid, mandelic acid, and amino fruit acids are also gradually used in clinical practice. These peeling agents can dissolve keratinocytes, reduce the adherence of corneocytes, promote exfoliation of the epidermis, and induce the production of new collagen fibers. 27 Depending on the strength of the chemical peel, it can improve various skin problems, including acne and acne scars, photoaging, dyschromia, and precancerous lesions.
A previous study has shown that regular use of these chemical peeling agents can improve the appearance of shallow acne scars and treat pigmentation disorders. 28 The use of combination acids, such as salicylic, mandelic peels (SMPs), and retinoic acid‐glycolic acid (RAGA), is more effective for the treatment of acne scars. 29 Combining glycolic acid or ethanol peels with 35% TCA can further enhance penetration and treat more severe acne scars by strengthening the middle‐depth skin. 30 , 31 However, due to limited penetration depth, superficial and medium‐depth peeling is mostly limited to mild atrophic scars or acne‐related pigmentation disorders. 32
For deeper atrophic scars, especially ice‐pick scars, deeper peeling agents like TCA (>50%) are required, which destroy the epidermal cells, cause necrosis of the epidermal and upper dermal cells, penetrate the reticular dermis, and coagulate proteins. When applied to the skin, it will produce typical white frost, indicating the precipitation and necrosis of proteins. Within a few days after treatment, the necrotic skin layer will fall off, and the treatment area will be re‐epithelialized with surrounding healthy skin. From a long‐term perspective, TCA treatment can stimulate the production of new collagen fibers. 13
Chemical Reconstruction of Skin Scars (CROSS) is another type of chemical peeling that applies high‐concentration acid to the bottom of scars using a sharp applicator tool while protecting the surrounding skin. 33 This method can maximize the effect of high‐concentration acid and minimize its complications by avoiding adjacent normal skin tissue and appendages. 34 Chemical peeling is a relatively safe and practical treatment method. Different depths of chemical peel agents can treat different types of acne scars. 35 It can be used alone or with other treatments. 36 Superficial chemical peel agents are suitable for shallow acne scars, 37 while medium‐depth and deep peel agents, 38 as well as combination therapies, are more advantageous in treating deeper acne scars. 28 , 39
Chemical peeling is convenient to operate, cost‐effective, and has a fast recovery time. The postoperative care of the affected area is simple, and patients generally have good acceptance. 40 In summary, chemical peeling is a safe and effective method of treating acne scars. 30 Practitioners should be proficient in the concentration and scope of application of chemical peel agents and possible complications and inform patients about the importance of sunscreen and appropriate skin care programs.
2.5. Skin fillers
Skin‐filling treatment is another mainstream method used to treat atrophic acne scars. It involves injecting medical materials into the scarred area to raise the depressed part to the level of the normal surrounding skin. Different skin fillers have different durations and can be divided into short‐acting, semi‐permanent, and permanent fillers. In addition, different fillers have different durability due to variations in their biodegradability. 41
Common short‐term fillers include hyaluronic acid (HA) and exogenous collagen fillers. HA is a highly biodegradable substance that can be naturally decomposed by hyaluronidase in the body. 42 With the advancement of technology, HA can now be stabilized through cross‐linking, extending its clinical life to 6 to 18 months or more. 43 HA has both short‐term and long‐term effects. In the short term, its hydrophilicity can immediately increase the volume of subcutaneous tissue by retaining water in the dermis after injection. The long‐term effect is that HA activates fibroblasts to increase collagen synthesis in the following months, promoting additional soft tissue growth. 44 HA can be classified as monophasic (a uniform mixture of low and high molecular weight HAs) or biphasic (cross‐linked HAs in a non‐cross‐linked HA suspension). Another short‐term filler is exogenous collagen filler, which can come from pigs or cows. It is directly injected into the deep dermis to restore volume loss caused by facial acne scars. The main disadvantage of collagen fillers is their potential allergenicity, which must be tested for each patient several weeks before injection. 45 Later, a more durable glutaraldehyde collagen filler was developed, which, unlike previous bovine‐derived collagen fillers, not only corrected facial acne scars better but also did not cause allergic reactions at the injection site. 46
Semi‐permanent fillers: Poly‐L‐lactic acid (PLLA) and Calcium Hydroxylapatite (CaHA). PLLA has a semi‐permanent biological stimulating effect, 47 which can directly stimulate fibroblasts in the dermis to produce collagen. 48 Unlike HA, the effect of PLLA does not appear immediately, and it takes several weeks to several months to achieve optimal collagen production and ECM remodeling. 47 It has been reported that PLLA can maintain the correction of rolling acne scars for up to 4 years. 49 However, the correction effect of PLLA on ice‐pick scars is very small. 32 In addition, PLLA also carries risks of bruising, erythema, pain, and nodule formation, especially when improperly administered. 50
CaHA is another type of semi‐permanent filler that stimulates collagen production and the formation of fibrous tissue. CaHA filler consists of microspheres suspended in a carboxymethylcellulose gel. Unfortunately, research has found that CaHA fillers can cause transient erythema, bruising, hematomas, and occasional nodule formation as adverse reactions. 50 Permanent fillers: to improve the effectiveness, safety, and lifespan of collagen fillers, researchers have developed polymethylmethacrylate (PMMA) fillers. PMMA is an indecomposable synthetic polymer that can be used as subcutaneous fillers to enhance local soft tissue. 41 In a study, 90% of patients reported satisfaction after treatment with PMMA fillers, despite experiencing transient bruising, erythema, and pain in some injection sites. 51 However, since foreign body granuloma is delayed, long‐term follow‐up is still needed to assess the safety of PMMA fillers.
Atrophic acne scars can be filled with HA, polylactic acid, or hydroxyapatite calcium. 18 Although many fillers are effective in treating acne scars, clinical decision‐making about which filler to use needs to consider important factors such as patient needs, cost budgets and economic conditions, and patient concerns or choices regarding different durations and side effects of fillers.
2.6. Micro‐needling (MN) therapy
MN therapy is commonly used in cosmetic treatments. It is widely used for treating facial scars such as acne, fine lines, wrinkles, crow's feet, age spots, and other age‐related skin diseases. 52 , 53 Common MN devices include handheld roller devices with needles, automated needle pens, and micro‐needle matrix radiofrequency devices. 54 MN therapy involves creating hundreds of tiny pin‐sized holes in the skin to stimulate the regeneration of healthy skin. Many studies have reported increased epidermal thickness, upregulation of elastic protein fibers and collagen lattice formation, and the release of various regenerative growth factors in the days or weeks following treatment. 18 , 52 , 55 , 56 The tiny damage caused by the needle in the dermis can promote the synthesis of cell growth factors, increase collagen deposition, and reduce local inflammatory reactions. These changes in the dermis can improve the appearance of acne scars. 54 , 57 , 58 Additionally, MN therapy does not cause pigment deposition, so it is often used as an alternative to laser therapy for IV and V‐type skin. 59 Because MN therapy is relatively simple, has a quick recovery time, and low complication rate, MN is considered a practical and effective method of treating acne scars.
Studies have shown that MN therapy increases type I collagen expression. 60 , 61 In El‐Domyati's study, 10 patients received skin MN therapy every 2 weeks for six treatments. Skin biopsies were taken before the first treatment and 3 months after the last treatment, showing improvement in acne scars and a significant increase in type I, III, and VII collagen. 62 Tirmizi SS and others treated 50 patients with moderate to severe atrophic acne scars using MN therapy. They concluded that the appearance and grade of scars improved, indicating that MN effectively improves acne scars. 63
As a single treatment method, MN therapy is most effective for rolling scars, followed by boxcar scars, and has some improvement in ice‐pick scars. 64 , 65 , 66 , 67 Most studies show little improvement in ice‐pick scars, but Gupta and colleagues' study shows significant improvement. 66 These two results may be related to using different types of needles. 68 In addition, MN is also an effective transdermal drug delivery adjunct, with studies most commonly combining MN therapy with PRP. Numerous randomized controlled trials have reported mixed results on this combination therapy, with reports of significant improvements after adding PRP, while others report no significant differences. 69 , 70 By comparing these studies, the frequency, application, and duration of combination therapy vary, leading to significant differences in study results. Some have explored alternative products to PRP, such as insulin and amniotic fluid. Pawar and others found that boxcar scars responded better to insulin than PRP. 71 , 72 El‐Domyati and others found that local application of amniotic fluid using MN can increase epidermal thickness and new collagen formation. 72 In addition, many studies have shown that combining MN with chemical peels, such as TCA and glycolic acid, can improve patient outcomes. 62 , 67 However, one study has shown that Jessner's solution does not enhance the effectiveness of MN. 65 In these studies of MN therapy, erythema, edema, and pain are the most commonly reported side effects of MN, but they typically resolve on their own. 73
The effect of MN therapy is best for rolling and boxcar scars, but there is almost no improvement for ice‐pick scars. However, it can promote local transdermal drug delivery, increasing its versatility and making it a safe and effective method of combining with other treatment methods to improve and treat acne scars. In addition, patients are more satisfied with a combination of PRP and MN therapy than with MN alone. 62 , 67 Other combination therapies with higher patient satisfaction than MN alone include: MN with glycolic acid 67 and trichloroacetic acid. 62
2.7. Thread lifting surgery
Thread lifting is a simple, minimally invasive facial lifting surgery. In this process, barbed threads are inserted under the facial skin. The implanted threads can suspend the underlying tissues, lifting the skin and stimulating collagen synthesis by activating fibroblasts. Initially, non‐absorbable medical sutures were used for this method, which provided long‐term cosmetic improvement due to their biodegradability resistance and high tensile strength, but with potential infection risks and rejection reactions. Therefore, although the clinical efficacy duration of non‐absorbable threads is longer, they have been replaced by semi‐permanent absorbable threads. Although absorbable threads have a shorter correction time, they have greater biological compatibility and lower infection risk. 27 Donnarumma et al. used absorbable polydioxanone (PDO) barbed sutures to perform thread‐lifting surgery on five patients with boxcar scars as the main complaint. The results showed that the scars of all five patients were improved. After six months, the skin fibers appeared to have a more regular fibrous network in observation with reflectance confocal microscopy. The study did not report any adverse events. 74 However, the study's sample size needed to be bigger and more representative, and more research is needed to evaluate the efficacy and safety of thread lifting for acne scars. Additionally, different types of available threads and surgical techniques should be further analyzed for their reactions to different acne scars.
3. SURGICAL EXCISION
3.1. Dermabrasion
Dermabrasion is a common medical cosmetic technique used for skin resurfacing. It involves controlled mechanical abrasion of the superficial layers of the epidermis and dermis using a grinding wheel. It mainly induces reepithelialization, repigmentation, and neocollagenesis in the basal cells, spinous cells, and the remaining skin appendages such as hair follicle walls, sweat gland duct walls, and sebaceous gland duct walls. 27 Initially, the purpose of dermabrasion was to induce damage in the dermis above the reticular layer in a controlled manner. Therefore, it is particularly effective in treating shallow rolling and boxcar scars but has minimal clinical improvement in deeper ice pick scars. Usually, significant correction of acne scars can be achieved with a single dermabrasion procedure. However, the depth of dermabrasion should not be too deep, as penetrating the reticular layer of the dermis may lead to new scars. Therefore, the operator needs to be extra cautious during the operation. In addition, numerous reports of dermabrasion complications, such as persistent pain, erythema, and permanent dyschromia. 32 Although dermabrasion is still a simple and effective method for treating acne scars, it is gradually being replaced by other treatment methods due to its numerous complications and poor tolerability. Therefore, it is not the best choice among the various treatments for facial acne scars.
4. PUNCH EXCISION TREATMENT
Punch excision treatment includes punch elevation, punch excision, and punch grafting. Punch elevation is a method developed for sharp‐edged and flat‐bottomed boxcar scars. It is a technique of punching the scar to the subcutaneous tissue without causing tissue damage. The punctured scar is then lifted and sutured slightly higher than the surrounding skin to alleviate the contraction of scars after formation. 75 Punch elevation is suitable for ice pick and narrow boxcar scars. The operator uses a punch slightly larger than the scar to cut from the outer edge of the scar to the subcutaneous fat and then sutures the skin along the tension lines of the skin, thus transforming the more obvious ice pick and boxcar scars into less noticeable linear scars. Laser treatment can also be combined to improve scars 66 further. The punch excision method is the simplest punching technique and most effective for ice‐pick scars. 67 First, the ice pick scar needs to be found, and then it is removed with a punch slightly larger than the diameter of the scar, followed by suturing of the 2–3 mm hole. 76 For scars with a diameter greater than 3‐3.5 mm, an elliptical or fusiform closure should be performed to ensure the skin is flat and smooth. Although this method can remove multiple scars simultaneously, the distance between each scar should be at least 4–5 mm. It can prevent excessive tension on the skin after repairing the puncture site. If there is any residual scar, the next excision can be performed after the previous excision site has completely healed.
Similarly, linear scars after punch excision can be improved by laser treatment. 27 Although punch excision treatment is an effective technique for treating ice‐pick scars, it can result in a less conspicuous linear scar than the original acne scar. 27 Punch grafting can solve this problem using skin grafts, most commonly taken from behind the ear and tightly inserted into the puncture site. Ensuring that the graft is appropriate for a better fit is essential. However, some studies have reported graft suppression 4–6 weeks after punch excision, leading to irregular skin texture, which can be corrected by skin filling (such as collagen) or laser treatment. 27 Punch elevation elevates the cylindrical skin at the affected site without complete removal, so no irregular skin texture is observed in the graft. However, the disadvantage is that the scar will shrink and affect the healing of the edge of the punched tissue, leaving a conspicuous ring‐shaped scar. Nevertheless, punch techniques can be a last option for deep ice pick and boxcar scars that are difficult to treat with other methods.
4.1. Subcutaneous excision
Subcutaneous excision, or subcutaneous surgery without incisions, is commonly used to treat atrophic acne scars, depressed scars, wrinkles, and other similar conditions. The main improvement achieved through subcutaneous incision treatment is for rolling scars, and some research reports show that the effective improvement rate using standardized acne scar grading assessment tools (such as the Goodman and Baron qualitative grading system) is 100%. 77 However, isolated subcutaneous excision has proven ineffective for boxcar scars. 78 , 79 Some studies have reported that subcutaneous surgery without incisions can also improve scars caused by car accidents and ice picks. 79 , 80 , 81 , 82 Still, in these studies, subcutaneous surgery without incisions was combined with other non‐energy treatments, making it difficult to assess the efficacy of isolated subcutaneous excision for these types of scars. In addition, due to the nature of the surgery and the surgical tools used, there is a certain risk of nerve and blood vessel damage associated with subcutaneous excision, which may cause side effects such as hematoma formation, bruises, erythema and excessive pigmentation. 80 , 83 For example, Taylor et al. developed a new surgical instrument composed of a long metal rod with a “W” shaped blunt end and a sharp notch at the tip, which could effectively capture the fiber strands in rolling scars and cut them off as the rod advances through the subcutaneous plane, 84 , 85 improving the overall effectiveness of subcutaneous excision, but with a higher risk of damage to deep facial structures. 84 Most studies on isolated or combined subcutaneous excision with other therapies are more likely to have complications such as hematoma formation, bruises, erythema, and excessive pigmentation. 83 However, in recent years, metal wires and blunt cannulas have replaced the previously used Nokor needles and hollow needles, reducing the incidence of complications and achieving similar or even better outcome results. 77 , 80 , 86
Subcutaneous excision surgery can also be combined with other commonly used scar treatment methods, such as microneedle therapy, laser therapy, etc. A randomized split‐face study conducted by Alaa et al. showed that combining subcutaneous excision surgery with CO2 fractional laser or HA subcutaneous injection had better therapeutic effects on facial atrophic acne scars. Their study also showed no statistically significant difference in treatment effects between the HA injection and CO2 laser groups. 18 Some studies have found that combining subcutaneous excision surgery with microneedling and platelet‐rich plasma (PRP) can improve acne scars. 79 , 81 , 87 Moreover, PRP can improve the therapeutic effects of acne scars and reduce the incidence of complications. 87 It should be noted that only by carefully operating the surgical tools and fully understanding the facial anatomy can the maximum clinical efficacy and safety of patients be achieved, which places higher demands on operators. Subcutaneous excision surgery is still a good option for rolling or box scars patients.
5. COMBINED THERAPY
Combined therapy for acne scars uses two or more treatment methods to improve acne scars. This approach can improve acne scars from multiple angles and achieve a “1+1 > 2” effect by utilizing the complementary effects of different treatment methods. Currently, the most researched combined therapies include laser and platelet‐rich plasma (PRP) injections. PRP is an autologous blood derivative rich in platelets, growth factors, and cell signaling molecules. When delivered in the form of plasma, PRP has the potential to transport high concentrations of growth factors to target tissues. 88 In a study by Lee et al., two groups of subjects received lattice laser treatment in combination with either PRP or saline. The results showed a greater improvement in the PRP group than in the saline group. 89 Mumtaz et al. compared the efficacy of PRP with 50% TCA (trichloroacetic acid) using the CROSS method and found that PRP was significantly superior to 50% TCA in improving atrophic acne scars. 55 Bhargava et al. conducted a study using PRP as an adjunct therapy to subcision and microneedling for severe atrophic acne scar formation. One group received subcision and MN treatment; the other group received subcision, MN, and local PRP application. The results showed that the group with PRP had better efficacy. 81 Nilforoushzadeh et al. treated atrophic acne scars using autologous adipose‐derived stem cells, matrix vascular stem cells, and PRP. Nine patients received adipose‐derived stem cell transplantation, PRP, and matrix vascular stem cells. After six months, improvements were observed in skin brightness, skin elasticity, transepidermal water loss, pigmentation, and skin pores. 90 In the treatment of atrophic facial acne scars, Lotfi L. conducted a preliminary investigational study demonstrating the potential efficacy of adjunct radiofrequency microneedle stimulation combined with poly‐caprolactone‐based dermal filler. 91 In a split‐face study, Chawla et al. compared the use of MN with PRP on one side and MN with vitamin C on the other, with a treatment interval of one month. The results showed that the PRP group responded better than the MN+vitamin C group. 92 Overall, combined therapy is superior to a single therapy, but further exploration is needed to select the optimal treatment combination from a wide range of treatment options.
6. EMERGING THERAPIES
Emerging therapies mainly refer to certain stem cells and cytokines, such as MSCs, growth factors, exosomes, etc. MSCs are a kind of adult stem cells that originate from the mesoderm with self‐renewal, self‐repair, and differentiation potential, which can be derived from various tissues, including bone marrow, adipose tissue, amniotic fluid, umbilical cord blood, dental pulp, peripheral blood, hair follicles, etc. Currently, they have been applied in the field of plastic and reconstructive surgery. 93 , 94 Epidermal growth factor ointment (EGFO) can accelerate skin healing by stimulating, migrating, and proliferating mesenchymal and epidermal cells. 95 Dong Hyo Kim et al. have demonstrated that EGFO effectively improves acne vulgaris and scars clinically and histologically. In addition, they found that EGFO can reduce inflammation and abnormal keratinization and promote scar regeneration through immunohistochemical analysis. 96
Recent studies have shown that exosomes derived from human adipose tissue stem cells (ASCE) have stem cell key features and are as effective as MSCs in repairing various organ injuries. 97 , 98 Hyuck Hoon KWON et al. studied the efficacy of carbon dioxide fractional laser combined with exosomes (derived from adipose tissue stem cells) in treating acne scars. The results showed that the exosome group had a significantly higher improvement rate (32.5% vs. 19.9%), the redness was lighter, and the recovery was faster. 99 Traditional therapies for acne scars, such as chemical peeling, phototherapy, and microneedling, mostly cause slight skin damage, 2 , 32 , 100 which may lead to related complications during treatment.
7. DISCUSSION
The efficacy of phototherapy for acne scars is lower for patients with darker skin tones compared to those with lighter skin tones. It poses higher risks of pigment loss and even hypopigmentation and can cause redness, swelling, and hyperpigmentation in people with darker skin tones. In addition, it must be combined with topical medication to promote wound healing, limiting its use. Microneedling therapy is a common technique for improving acne scars, and many studies have shown that it can improve the appearance of acne scars. However, these studies have yet to achieve uniform results in the degree of improvement consistently, and the results of studies comparing microneedling monotherapy with combination therapy are also inconsistent. However, most studies have shown that microneedling combined with other therapies such as TCA (trichloroacetic acid), glycolic acid, or CO2 laser spot irradiation is better than microneedling monotherapy. 98 Although dermal filling treatment has some effect on improving acne scars, it requires repeated injections over time. Thread lifting, conversely, does not have an immediate effect after treatment and may take a long time to observe its efficacy. In addition, if absorbable sutures are used in the thread lifting procedure, the durability is poor, while non‐absorbable sutures pose a risk of foreign body infection, and therefore, this method is now rarely used. Dermabrasion for acne scar treatment is now rarely used due to its high operator demands, high degree of difficulty, prominent complications, and poor treatment experience. Subcutaneous excision surgery as an invasive operation has potential risks of nerve and vascular damage, subcutaneous hematoma formation, and ecchymosis and has been gradually replaced by other treatment modalities. Although punch grafting can solve more challenging ice‐pick scars, residual linear scars may still exist. Punch elevation surgery may leave less obvious circular scars, but the effectiveness of these two methods still needs to be improved when used alone.
Emerging treatment methods mainly rely on some biologically active substances to exert anti‐inflammatory, anti‐fibrotic, and regulate extracellular matrix remodeling effects to improve acne scars. However, the preparation methods of stem cells and their derivatives could be more convenient, the treatment dosage has no unified standard, the transplantation routes and efficacy cannot be determined, and the use of stem cells still raises ethical controversy, which limits their clinical application. Although extracellular vesicles have fewer restrictions in clinical use, the preparation process could be more convenient, and there may be biological contamination risks during cell separation and in vitro culture, which also limit their clinical use. In addition, a patient's physical condition, genetics, age, and Fitzpatrick skin type can all affect their response to treatment and their ability to produce collagen in the skin, thus affecting treatment outcomes.
8. CONCLUSION
Currently, acne scars remain a challenge for dermatologists as a common sequela of acne vulgaris. Scientific research and clinical trials to improve acne scars are still hot research topics in medicine. There are now many effective ways to improve acne scars. Still, each acne treatment method has its advantages and disadvantages, which can be optimized by combination therapy to achieve better results. The specific treatment plan should be individualized according to the patient's situation. Before implementing a treatment plan, experimental treatment of scars can be conducted on a small scale to evaluate efficacy and safety. At the same time, the design of treatment plans should also consider other factors such as patient expectations, recovery time, and economic costs. In summary, proper treatment methods, correct skin care, and timely medical attention can help achieve the best treatment outcome.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflicts of interest.
ACKNOWLEDGMENTS
We thank our colleagues in the Department of Dermatology, the First Affiliated Hospital of Ningbo University, for their selfless help. Thank the reviewers for their valuable comments. This study was supported by the Project of Ningbo Leading Medical & Health Discipline (No. 2022‐F23) and the Ningbo Natural Science Foundation (No. 202003N4241).
Miao L, Ma Y, Liu Z, Ruan H, Yuan B. Modern techniques in addressing facial acne scars: A thorough analysis. Skin Res Technol. 2024;30:e13573. 10.1111/srt.13573
DATA AVAILABILITY STATEMENT
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
REFERENCES
- 1. Zaenglein AL. Acne vulgaris. N Engl J Med. 2018;379(14):1343–1352. doi: 10.1056/NEJMcp1702493 [DOI] [PubMed] [Google Scholar]
- 2. Connolly D, Vu HL, Mariwalla K, Saedi N. Acne scarring‐pathogenesis, evaluation, and treatment options. J Clin Aesthet Dermatol. 2017;10(9):12–23. [PMC free article] [PubMed] [Google Scholar]
- 3. Liu L, Xue Y, Chen Y, et al. Prevalence and risk factors of acne scars in patients with acne vulgaris. Skin Res Technol. 2023;29(6):e13386. doi: 10.1111/srt.13386 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Malinowska S, Jaguś D, Woźniak W, Mlosek R K. Usefulness of high‐frequency ultrasound in the monitoring of laser treatment of acne scars. J Ultrason. 2021;20(83):e279–e283. doi: 10.15557/JoU.2020.0049 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Park SY, Park MY, Suh DH, et al. Cross‐sectional survey of awareness and behavioral pattern regarding acne and acne scar based on smartphone application. Int J Dermatol. 2016. 55(6):645–652. doi: 10.1111/ijd.12853 [DOI] [PubMed] [Google Scholar]
- 6. Guo R, Xuan W, He X, Xu K. Clinical efficacy and safety of pulsed dye laser combined with pingyangmycin on hyperplastic scar after acne. Mediators Inflamm. 2022. 2022:3305107. doi: 10.1155/2022/3305107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Chun Q, ZhiYong W, Fei S, XiQiao W. Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression. Int Wound J. 2016;13(2):257–262. doi: 10.1111/iwj.12283 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Xu X, Lai L, Zhang X. Autologous chyle fat grafting for the treatment of hypertrophic scars and scar‐related conditions. Stem Cell Res Ther. 2018;9(1):64. doi: 10.1186/s13287-018-0782-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Wu N, Sun H, Sun Q. A meta‐analysis of fractional CO2 laser combined with PRP in the treatment of acne scar. Lasers Med Sci. 2021;36(1):1–12. doi: 10.1007/s10103-020-03105-z [DOI] [PubMed] [Google Scholar]
- 10. Tan J, Kang S, Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA. J Drugs Dermatol. JDD, 2017;16(2):97–102. [PubMed] [Google Scholar]
- 11. Liu S, Fan Y, Duan M. AcneGrader: an ensemble pruning of the deep learning base models to grade acne. Skin Res Technol. 2022. 28(5):677–688. doi: 10.1111/srt.13166 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Xu Y, Deng Y. Ablative fractional CO2 laser for facial atrophic acne scars. Facial Plast Surg. 2018;34(2):205–219. doi: 10.1055/s-0037-1606096 [DOI] [PubMed] [Google Scholar]
- 13. Chilicka K, Rusztowicz M, Szyguła R, Nowicka D. Methods for the improvement of acne scars used in dermatology and cosmetology: a review. J Clin Med. 2022;11(10):2744. doi: 10.3390/jcm11102744 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Magnani LR, Schweiger ES. Fractional CO2 lasers for the treatment of atrophic acne scars: a review of the literature. J Cosmet Laser Ther. 2014;16(2):48–56. doi: 10.3109/14764172.2013.854639 [DOI] [PubMed] [Google Scholar]
- 15. Fang F, Yang H, Liu X, et al. Treatment of acne scars with fractional carbon dioxide laser in Asians: a retrospective study to search for predicting factors associated with efficacy. Lasers Med Sci. 2022;37(6):2623–2627. doi: 10.1007/s10103-022-03528-w [DOI] [PubMed] [Google Scholar]
- 16. Galal O, Tawfik AA, Abdalla N, Soliman M. Fractional CO2 laser versus combined platelet‐rich plasma and fractional CO2 laser in treatment of acne scars: Image analysis system evaluation. J Cosmet Dermatol. 2019;18(6):1665–1671. doi: 10.1111/jocd.12909 [DOI] [PubMed] [Google Scholar]
- 17. Zhou BR, Zhang T, Bin Jameel AA. The efficacy of conditioned media of adipose‐derived stem cells combined with ablative carbon dioxide fractional resurfacing for atrophic acne scars and skin rejuvenation. J Cosmet Laser Ther. 2016;18(3):138–148. doi: 10.3109/14764172.2015.1114638 [DOI] [PubMed] [Google Scholar]
- 18. Abdelwahab AA, Omar GAB, Hamdino M. A combined subcision approach with either fractional CO2 laser (10,600 nm) or cross‐linked hyaluronic acid versus subcision alone in atrophic post‐acne scar treatment. Lasers Med Sci. 2022;38(1):20. doi: 10.1007/s10103-022-03677-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Cho SB, Lee SJ, Cho S, et al. Non‐ablative 1550‐nm erbium‐glass and ablative 10 600‐nm carbon dioxide fractional lasers for acne scars: a randomized split‐face study with blinded response evaluation. J Eur Acad Dermatol Venereol. 2010. 24(8):921–925. doi: 10.1111/j.1468-3083.2009.03551.x [DOI] [PubMed] [Google Scholar]
- 20. Chan NP, Ho SG, Yeung CK, Shek SY, Chan HH. Fractional ablative carbon dioxide laser resurfacing for skin rejuvenation and acne scars in Asians. Lasers Surg Med. 2010;42(9):615–623. doi: 10.1002/lsm.20974 [DOI] [PubMed] [Google Scholar]
- 21. Katz B. Efficacy of a new fractional CO2 laser in the treatment of photodamage and acne scarring. Dermatol Ther. 2010;23(4):403–406. doi: 10.1111/j.1529-8019.2010.01340.x [DOI] [PubMed] [Google Scholar]
- 22. Cannarozzo G, Bennardo L, Zingoni T, Pieri L, Duca ED, Nisticò S P. Histological skin changes after treatment with 675 nm laser. Photobiomodul Photomed Laser Surg. 2021;39(9):617–621. doi: 10.1089/photob.2020.4927 [DOI] [PubMed] [Google Scholar]
- 23. Cannarozzo G, Silvestri M, Tamburi F, et al. A new 675‐nm laser device in the treatment of acne scars: an observational study. Lasers Med Sci. 2021;36(1):227–231. doi: 10.1007/s10103-020-03063-6 [DOI] [PubMed] [Google Scholar]
- 24. Rogachefsky AS, Hussain M, Goldberg DJ. Atrophic and a mixed pattern of acne scars improved with a 1320‐nm Nd:YAG laser. Dermatol Surg. 2003;29(9):904–908. doi: 10.1046/j.1524-4725.2003.29256.x [DOI] [PubMed] [Google Scholar]
- 25. Sadick NS, Schecter AK. A preliminary study of utilization of the 1320‐nm Nd:YAG laser for the treatment of acne scarring. Dermatol Surg. 2004:30(7):995–1000. doi: 10.1111/j.1524-4725.2004.30304.x [DOI] [PubMed] [Google Scholar]
- 26. Lee SR, Cho S. Clinical factors affecting the effectiveness of 1550‐nm erbium‐doped fractional photothermolysis laser for individual atrophic acne scar types. Dermatol Ther. 2023;13(2):609–616. doi: 10.1007/s13555-022-00887-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Tam C, Khong J, Tam K, Vasilev R, Wu W, Hazany S. A comprehensive review of non‐energy‐based treatments for atrophic acne scarring. Clin Cosmet Investig Dermatol. 2022;15:455–469. doi: 10.2147/CCID.S350040 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. O'Connor AA, Lowe PM, Shumack S, Lim AC. Chemical peels: a review of current practice. Australas J Dermatol. 2018;59(3):171–181. doi: 10.1111/ajd.12715 [DOI] [PubMed] [Google Scholar]
- 29. Chandrashekar BS, Ashwini KR, Vasanth V, Navale S. Retinoic acid and glycolic acid combination in the treatment of acne scars. Indian Dermatol Online J. 2015;6(2):84–88. doi: 10.4103/2229-5178.153007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Puri N. Efficacy of modified Jessner's Peel and 20% TCA versus 20% TCA peel alone for the treatment of acne scars. J Cutan Aesthet Surg. 2015;8(1):42–45. doi: 10.4103/0974-2077.155082 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Gozali MV, Zhou B. Effective treatments of atrophic acne scars. J Clin Aesthet Dermatol. 2015;8(5):33–40. [PMC free article] [PubMed] [Google Scholar]
- 32. Boen M, Jacob C. A review and update of treatment options using the acne scar classification system. Dermatol Surg. 2019;45(3):411–422. doi: 10.1097/DSS.0000000000001765 [DOI] [PubMed] [Google Scholar]
- 33. Lee JB, Chung WG, Kwahck H, Lee KH. Focal treatment of acne scars with trichloroacetic acid: chemical reconstruction of skin scars method. Dermatol Surg. 2002;28(11):1017–1021. doi: 10.1046/j.1524-4725.2002.02095.x [DOI] [PubMed] [Google Scholar]
- 34. Agarwal N, Gupta LK, Khare AK, Kuldeep CM, Mittal A. Therapeutic response of 70% trichloroacetic acid CROSS in atrophic acne scars. Dermatol Surg. 2015;41(5):597–604. doi: 10.1097/DSS.0000000000000355 [DOI] [PubMed] [Google Scholar]
- 35. Khunger N, Bhardwaj D, Khunger M. Evaluation of CROSS technique with 100% TCA in the management of ice pick acne scars in darker skin types. J Cosmet Dermatol. 2011;10(1):51–57. doi: 10.1111/j.1473-2165.2010.00526.x [DOI] [PubMed] [Google Scholar]
- 36. Al‐Hamamy HR, Al‐Dhalimi MA, Abtan AF. Evaluation of treatment of acne scars with 25% trichloroacetic acid chemical peel followed by manual dermasanding. J Cosmet Dermatol.. 2021. 20(6):1750–1755. doi: 10.1111/jocd.13754 [DOI] [PubMed] [Google Scholar]
- 37. Fabbrocini G, Cacciapuoti S, Fardella N, Pastore F, & Monfrecola G. CROSS technique: chemical reconstruction of skin scars method. Dermatol Ther. 2008. 21 Suppl 3:S29–S32. doi: 10.1111/j.1529-8019.2008.00239.x [DOI] [PubMed] [Google Scholar]
- 38. Chung HJ, Al Janahi S, Cho SB, Chang YC. Chemical reconstruction of skin scars (CROSS) method for atrophic scars: a comprehensive review. J Cosmet Dermatol. 2021;20(1):18–27. doi: 10.1111/jocd.13556 [DOI] [PubMed] [Google Scholar]
- 39. Hevia O, Nemeth AJ, Taylor JR. Tretinoin accelerates healing after trichloroacetic acid chemical peel. Arch Dermatol. 1991;127(5):678–682. [PubMed] [Google Scholar]
- 40. Dalpizzol M, Weber MB, Mattiazzi AP, Manzoni AP. Comparative study of the use of trichloroacetic acid and phenolic acid in the treatment of atrophic‐type acne scars. Dermatol Surg. 2016;42(3):377–383. doi: 10.1097/DSS.0000000000000606 [DOI] [PubMed] [Google Scholar]
- 41. Gold MH, Sadick NS. Optimizing outcomes with polymethylmethacrylate fillers. J Cosmet Dermatol. 2018;17(3):298–304. doi: 10.1111/jocd.12539 [DOI] [PubMed] [Google Scholar]
- 42. Buhren BA, Schrumpf H, Bölke E, Kammers K, Gerber PA. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase. Eur J Med Res. 2018;23(1):37. doi: 10.1186/s40001-018-0334-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Hussain SN, Goodman GJ, Rahman E. Treatment of a traumatic atrophic depressed scar with hyaluronic acid fillers: a case report. Clin Cosmet Investig Dermatol. 2017;10:285–287. doi: 10.2147/CCID.S132626 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Turlier V, Delalleau A, Casas C, et al. Association between collagen production and mechanical stretching in dermal extracellular matrix: in vivo effect of cross‐linked hyaluronic acid filler. A randomised, placebo‐controlled study. J Dermatol Sci. 2013;69(3):187–194. doi: 10.1016/j.jdermsci.2012.12.006 [DOI] [PubMed] [Google Scholar]
- 45. Lee JH, Choi YS, Kim SM, Kim YJ, Rhie JW, Jun YJ. Efficacy and safety of porcine collagen filler for nasolabial fold correction in Asians: a prospective multicenter, 12 months follow‐up study. J Korean Med Sci. 1988. 29 Suppl 3(Suppl 3), S217–S221. doi: 10.3346/jkms.2014.29.S3.S217 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Elson ML. Clinical assessment of Zyplast Implant: a year of experience for soft tissue contour correction. J Am Acad Dermatol. 1988;18(4 Pt 1):707–713. doi: 10.1016/s0190-9622(88)70094-8 [DOI] [PubMed] [Google Scholar]
- 47. Fitzgerald R, Bass LM, Goldberg DJ, Graivier MH, Lorenc Z P. Physiochemical Characteristics of Poly‐L‐Lactic Acid (PLLA). Aesthet Surg J. 2018. 38(suppl_1), S13–S17. doi: 10.1093/asj/sjy012 [DOI] [PubMed] [Google Scholar]
- 48. Kim SA, Kim HS, Jung JW, Suh SI, Ryoo YW. Poly‐L‐lactic acid increases collagen gene expression and synthesis in cultured dermal fibroblast (Hs68) through the p38 MAPK pathway. Ann Dermatol. 2019;31(1):97–100. doi: 10.5021/ad.2019.31.1.97 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Sapra S, Stewart J A, Mraud K, Schupp R. A Canadian study of the use of poly‐L‐lactic acid dermal implant for the treatment of hill and valley acne scarring. Dermatol Surg. 2015;41(5):587–594. doi: 10.1097/DSS.0000000000000366 [DOI] [PubMed] [Google Scholar]
- 50. Kadouch JA. Calcium hydroxylapatite: a review on safety and complications. J Cosmet Dermatol. 2017;16(2), 152–161. doi: 10.1111/jocd.12326 [DOI] [PubMed] [Google Scholar]
- 51. Joseph JH, Shamban A, Eaton L, et al. Polymethylmethacrylate collagen gel‐injectable dermal filler for full face atrophic acne scar correction. Dermatol Surg. 2019;45(12):1558–1566. doi: 10.1097/DSS.0000000000001863 [DOI] [PubMed] [Google Scholar]
- 52. Chilicka K, Dzieńdziora‐Urbińska I, Szyguła R, Asanova B, Nowicka D. Microbiome and probiotics in acne vulgaris‐a narrative review. Life (Basel, Switzerland). 2022;12(3):422. doi: 10.3390/life12030422 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Chilicka K, Rogowska AM, Rusztowicz M, et al. The effects of green tea (Camellia sinensis), bamboo extract (Bambusa vulgaris) and lactic acid on sebum production in young women with acne vulgaris using sonophoresis treatment. 2022. Healthcare (Basel, Switzerland). 10(4):684. doi: 10.3390/healthcare10040684 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Ramaut L, Hoeksema H, Pirayesh A, Stillaert F, Monstrey S. Microneedling: where do we stand now? A systematic review of the literature. J Plast Reconstr Aesthet. 2018;71(1):1–14. doi: 10.1016/j.bjps.2017.06.006 [DOI] [PubMed] [Google Scholar]
- 55. Mumtaz M, Hassan T, Shahzad M K, Hanif N, Anwar S, & Anjum R. Comparing the efficacy of intra‐dermal platelet rich plasma (PRP) versus 50% trichloracetic acid (TCA) using cross technique for atrophic acne scars. J Coll Physicians Surg Pak. 2021. JCPSP, 31(1):55–59. doi: 10.29271/jcpsp.2021.01.55 [DOI] [PubMed] [Google Scholar]
- 56. Nilforoushzadeh MA, Fakhim T, Heidari‐Kharaji M, Hanifnia A R, Hejazi S, Torkamaniha E. Efficacy evaluation of Endolift‐based Subcision on acne scar treatment. J Cosmet Dermatol. 2021;20(8):2579–2582. doi: 10.1111/jocd.13876 [DOI] [PubMed] [Google Scholar]
- 57. Kwon HH, Park HY, Choi SC, Bae Y, Jung JY, Park G H. Novel device‐based acne treatments: comparison of a 1450‐nm diode laser and microneedling radiofrequency on mild‐to‐moderate acne vulgaris and seborrhoea in Korean patients through a 20‐week prospective, randomized, split‐face study. J Eur Acad Dermatol Venereol. 2018;32(4):639–644. doi: 10.1111/jdv.14714 [DOI] [PubMed] [Google Scholar]
- 58. Osman MA, Shokeir HA, Fawzy MM. Fractional erbium‐doped yttrium aluminum garnet laser versus microneedling in treatment of atrophic acne scars: a randomized split‐face clinical study. Dermatol Surg. 2017;43 Suppl 1:S47–S56. doi: 10.1097/DSS.0000000000000951 [DOI] [PubMed] [Google Scholar]
- 59. Juhasz MLW, Cohen JL. Microneedling for the treatment of scars: an update for clinicians. Clin Cosmet Investig Dermatol. 2020;13:997–1003. doi: 10.2147/CCID.S267192 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Moftah NH, El Khayyat MAM, Ragai MH, Alaa H. Carboxytherapy versus skin microneedling in treatment of atrophic postacne scars: a comparative clinical, histopathological, and histometrical study. Dermatol Surg. 2018;44(10):1332–1341. doi: 10.1097/DSS.0000000000001560 [DOI] [PubMed] [Google Scholar]
- 61. Busch K H, Aliu A, Walezko N, & Aust M. Medical needling: effect on skin erythema of hypertrophic burn scars. Cureus. 2018;10(9):e3260. doi: 10.7759/cureus.3260 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. El‐Domyati M, Abdel‐Wahab H, Hossam A. Microneedling combined with platelet‐rich plasma or trichloroacetic acid peeling for management of acne scarring: a split‐face clinical and histologic comparison. J Cosmet Dermatol. 2018;17(1):73–83. doi: 10.1111/jocd.12459 [DOI] [PubMed] [Google Scholar]
- 63. Tirmizi SS, Iqbal T, Mansoor M, et al. Role of microneedling in atrophic post‐acne scars: an experience from a tertiary care hospital. Cureus. 2021;13(1):e12578. doi: 10.7759/cureus.12578 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Bandral MR, Padgavankar PH, Japatti SR, Gir PJ, Siddegowda CY, Gir RJ. Clinical evaluation of microneedling therapy in the management of facial scar: a prospective randomized study. J Maxillofac Oral Surg. 2019;18(4):572–578. doi: 10.1007/s12663-018-1155-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Ali B, ElMahdy N, Elfar NN. Microneedling (Dermapen) and Jessner's solution peeling in treatment of atrophic acne scars: a comparative randomized clinical study. J Cosmet Laser Ther. 21(6):357–363. doi: 10.1080/14764172.2019.1661490 [DOI] [PubMed] [Google Scholar]
- 66. Gupta A, Kaur M, Patra S, Khunger N, Gupta S. Evidence‐based surgical management of post‐acne scarring in skin of color. J Cutan Aesthet Surg. 2020;13(2):124–141. doi: 10.4103/JCAS.JCAS_154_19 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Rana S, Mendiratta V, Chander R. Efficacy of microneedling with 70% glycolic acid peel vs microneedling alone in treatment of atrophic acne scars‐a randomized controlled trial. J Cosmet Dermatol. 2017;16(4):454–459. doi: 10.1111/jocd.12377 [DOI] [PubMed] [Google Scholar]
- 68. Gupta M, Barman KD, Sarkar R. A comparative study of microneedling alone versus along with platelet‐rich plasma in acne scars. J Cutan Aesthet Surg. 2021;14(1):64–71. doi: 10.4103/JCAS.JCAS_190_20 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Porwal S, Chahar YS, Singh PK. A comparative study of combined dermaroller and platelet‐rich plasma versus dermaroller alone in acne scars and assessment of quality of life before and after treatment. Indian J Dermatol. 2018;63(5):403–408. doi: 10.4103/ijd.IJD_118_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Ebrahimi Z, Alimohamadi Y, Janani M, Hejazi P, Kamali M, Goodarzi A. Platelet‐rich plasma in the treatment of scars, to suggest or not to suggest? A systematic review and meta‐analysis. J Tissue Eng Regen Med. 2022;16(10):875–899. doi: 10.1002/term.3338 [DOI] [PubMed] [Google Scholar]
- 71. Pawar M, Singh M. Microneedling with autologous platelet‐rich plasma versus microneedling with topical insulin in the treatment of postacne atrophic scars: a simultaneous split‐face comparative study. J Am Acad Dermatol. 2021;84(3):810–811. doi: 10.1016/j.jaad.2020.05.152 [DOI] [PubMed] [Google Scholar]
- 72. El‐Domyati M, Moftah NH, Nasif GA, Ragaie MH, Ibrahim MR, Ameen SW. Amniotic fluid‐derived mesenchymal stem cell products combined with microneedling for acne scars: a split‐face clinical, histological, and histometric study. J Cosmet Dermatol. 2019;18(5):1300–1306. doi: 10.1111/jocd.13039 [DOI] [PubMed] [Google Scholar]
- 73. Gowda A, Healey B, Ezaldein H, Merati M. A systematic review examining the potential adverse effects of microneedling. J Clin Aesthet Dermatol. 2021;14(1):45–54. [PMC free article] [PubMed] [Google Scholar]
- 74. Donnarumma M, Vastarella M, Ferrillo M, Cantelli M, D'Andrea M, Fabbrocini G. An innovative treatment for acne scars with thread‐lift technique: our experience. Ital J Dermatol Venerol. 2021;156. (Suppl. 1 to No. 6):40–41. doi: 10.23736/S2784-8671.19.06313-2 [DOI] [PubMed] [Google Scholar]
- 75. Bhargava S, Cunha PR, Lee J, Kroumpouzos G. acne scarring management: systematic review and evaluation of the evidence. Am J Clin Dermatol. 2018;19(4):459–477. doi: 10.1007/s40257-018-0358-5 [DOI] [PubMed] [Google Scholar]
- 76. Fife D. Practical evaluation and management of atrophic acne scars: tips for the general dermatologist. J Clin Aesthet Dermatol. 2011;4(8):50–57. [PMC free article] [PubMed] [Google Scholar]
- 77. Nilforoushzadeh MA, Lotfi E, Heidari‐Kharaji M, Nickhah N, Alavi S, Mahmoudbeyk M. Comparing cannula‐based subcision with the common needle method: a clinical trial. Skin Res Technol. 2020;26(1):39–44. doi: 10.1111/srt.12761 [DOI] [PubMed] [Google Scholar]
- 78. Ramadan SA, El‐Komy MH, Bassiouny DA, El‐Tobshy SA. Subcision versus 100% trichloroacetic acid in the treatment of rolling acne scars. Dermatol Surg. 2011;37(5):626–633. doi: 10.1111/j.1524-4725.2011.01954.x [DOI] [PubMed] [Google Scholar]
- 79. Bhargava S, Kumar U, Varma K. Subcision and microneedling as an inexpensive and safe combination to treat atrophic acne scars in dark skin: a prospective study of 45 patients at a tertiary care center. J Clin Aesthet Dermatol. 2019;12(8):18–22. [PMC free article] [PubMed] [Google Scholar]
- 80. Barikbin B, Akbari Z, Yousefi M, Dowlati Y. Blunt blade subcision: an evolution in the treatment of atrophic acne scars. Dermatol Surg. 2017. 43 Suppl 1. S57–S63. doi: 10.1097/DSS.0000000000000650 [DOI] [PubMed] [Google Scholar]
- 81. Bhargava S, Kroumpouzos G, Varma K, Kumar U. Combination therapy using subcision, needling, and platelet‐rich plasma in the management of grade 4 atrophic acne scars: a pilot study. J Cosmet Dermatol. 2019;18(4):1092–1097. doi: 10.1111/jocd.12935 [DOI] [PubMed] [Google Scholar]
- 82. Aalami Harandi S, Balighi K, Lajevardi V, Akbari E. Subcision‐suction method: a new successful combination therapy in treatment of atrophic acne scars and other depressed scars. J Eur Acad Dermatol Venereol. 2011;25(1):92–99. doi: 10.1111/j.1468-3083.2010.03711.x [DOI] [PubMed] [Google Scholar]
- 83. Dadkhahfar S, Robati RM, Gheisari M, Moravvej H. Subcision: indications, adverse reactions, and pearls. J Cosmet Dermatol. 2020;19(5):1029–1038. doi: 10.1111/jocd.13308 [DOI] [PubMed] [Google Scholar]
- 84. Taylor M B, Zaleski‐Larsen L, McGraw TA. Single session treatment of rolling acne scars using tumescent anesthesia, 20% trichloracetic acid extensive subcision, and fractional Co2 laser. Dermatol Surg. 2017. 43(Suppl 1):S70–S74. doi: 10.1097/DSS.0000000000000895 [DOI] [PubMed] [Google Scholar]
- 85. Taylor MB, Koron N. Combined treatment of rolling acne scars in ethnic skin using extensive subcision, trichloracetic acid peel, and fractional ablative erbium laser. Dermatol Surg. 2021;47(4):496–499. doi: 10.1097/DSS.0000000000002858 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Gheisari M, Iranmanesh B, Saghi B. Blunt cannula subcision is more effective than Nokor needle subcision for acne scars treatment. J Cosmet Dermatol. 2019;18(1):192–196. doi: 10.1111/jocd.12523 [DOI] [PubMed] [Google Scholar]
- 87. Deshmukh NS, Belgaumkar VA (2019). Platelet‐rich plasma augments subcision in atrophic acne scars: a split‐face comparative study. Dermatol Surg. 45(1):90–98. doi: 10.1097/DSS.0000000000001614 [DOI] [PubMed] [Google Scholar]
- 88. Alser OH, Goutos I. The evidence behind the use of platelet‐rich plasma (PRP) in scar management: a literature review. Scars Burns Heal 2018;4:2059513118808773. doi: 10.1177/2059513118808773 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Lee JW, Kim BJ, Kim MN, Mun SK. The efficacy of autologous platelet rich plasma combined with ablative carbon dioxide fractional resurfacing for acne scars: a simultaneous split‐face trial. Dermatol Surg. 2011;37(7):931–938. doi: 10.1111/j.1524-4725.2011.01999.x [DOI] [PubMed] [Google Scholar]
- 90. Nilforoushzadeh M A, Heidari‐Kharaji M, Alavi S. Transplantation of autologous fat, stromal vascular fraction (SVF) cell, and platelet‐rich plasma (PRP) for cell therapy of atrophic acne scars: clinical evaluation and biometric assessment. J Cosmet Dermatol. 2022;21(5):2089–2098. doi: 10.1111/jocd.14333 [DOI] [PubMed] [Google Scholar]
- 91. Lotfi E, Shafie'ei M, Ahramiyanpour N. Radiofrequency‐assisted subcision combined with polycaprolactone‐based dermal fillers in the management of atrophic facial acne scars: a pilot investigative study. Skin Res Technol. 2022;28(6):865–871. doi: 10.1111/srt.13228 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Chawla S. Split face comparative study of microneedling with PRP versus microneedling with vitamin c in treating atrophic post acne scars. J Cutan Aesthet Surg. 2014;7(4):209–212. doi: 10.4103/0974-2077.150742 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Zhang C, Chen Y, Fu X. Sweat gland regeneration after burn injury: is stem cell therapy a new hope? Cytotherapy. 2015;17(5):526–535. doi: 10.1016/j.jcyt.2014.10.016 [DOI] [PubMed] [Google Scholar]
- 94. Deng C, Wang L, Feng J, Lu F. Treatment of human chronic wounds with autologous extracellular matrix/stromal vascular fraction gel: a STROBE‐compliant study. Medicine (Baltimore). 2018;97(32):e11667. doi: 10.1097/MD.0000000000011667 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Brown GL, Nanney LB, Griffen J, et al. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med. 1989;321(2):76–79. doi: 10.1056/NEJM198907133210203 [DOI] [PubMed] [Google Scholar]
- 96. Kim DH, Yang JH, Cho SI, et al. Clinical and histological effects of topical epidermal growth factor on acne and acne scars. Dermatology. 2022;238(5):837–845. doi: 10.1159/000521294 [DOI] [PubMed] [Google Scholar]
- 97. Lai RC, Yeo RW, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015;40:82–88. doi: 10.1016/j.semcdb.2015.03.001 [DOI] [PubMed] [Google Scholar]
- 98. Park JE, Tan HS, Datta A. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteom. 2010;9(6):1085–1099. doi: 10.1074/mcp.M900381-MCP200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99. Kwon HH, Yang SH, Lee J, et al. Combination treatment with human adipose tissue stem cell‐derived exosomes and fractional co2 laser for acne scars: a 12‐week prospective, double‐blind, randomized, split‐face study. Acta Derm Venereol. 2020;100(18):adv00310. doi: 10.2340/00015555-3666 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Kravvas G, Al‐Niaimi F. A systematic review of treatments for acne scarring. Part 1: non‐energy‐based techniques. Scars Burn Heal. 2017;3:2059513117695312. doi: 10.1177/2059513117695312 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.